• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION NAVICROSS; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION NAVICROSS; CATHETER, PERCUTANEOUS Back to Search Results
Model Number NC18151
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/07/2024
Type of Reportable Event Malfunction
Event or Problem Description
Tip of catheter peeled off outside of pt.Incident reported, credit issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVICROSS
Common Device Name
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
TERUMO CORPORATION
950 elkton blvd.
elkton MD 21921
MDR Report Key20321179
Report Number20321179
Device Sequence Number18167565
Product Code DQY
UDI-Device Identifier04987892077319
UDI-Public(01)04987892077319
Combination Product (Y/N)N
Initial Reporter StateWA
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type User Facility
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 05/23/2024
Report Date (Section F) 06/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberNC18151
Device Catalogue NumberPN*NA18153H
Device Lot Number231013
Was the Report Sent to FDA? Yes
Event Location Hospital
Date Report to Manufacturer09/27/2024
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date09/27/2024
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Patient Age52 YR
Patient SexMale
Date Report Sent to FDA06/06/2024
-
-